Soft Tissue Sarcoma
56-year-old man with a large undifferentiated pleomorphic sarcoma of the thigh
A 56-year-old man presented to the ED with 3 months of atraumatic left thigh pain.
Patients with sarcoma, mental health disorders may have poor outcomes
Published results showed patients with a mental health diagnosis who undergo surgery for bone or soft tissue sarcoma may be at risk for longer hospital stays, readmission and surgical site infection.
‘Most important study’ in soft tissue sarcomas in decades shows benefit of immunotherapy
CHICAGO — The addition of immunotherapy to radiation therapy and surgery significantly extended DFS for certain patients with soft tissue sarcoma, according to results of a randomized phase 2 trial.
Dana-Farber Cancer Institute names surgeon-in-chief
Chandrajit P. Raut, MD, MSc, has been appointed surgeon-in-chief at Dana-Farber Cancer Institute.
VIDEO: Cabozantinib, temozolomide promising for leiomyosarcoma
In a video interview, Sandra D’Angelo, MD, talked about a study of cabozantinib and temozolomide in patients with leiomyosarcoma and other soft tissue sarcomas, which was presented at the Connective Tissue Oncology Society Annual Meeting.
FDA grants breakthrough designation to colorectal cancer agent, fast tracks HNSCC therapy
The FDA announced several regulatory actions the past few weeks.
Researchers suggest avoiding excisional biopsies of soft tissue sarcoma of the hand
BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a longer time to patients’ first intervention vs. incisional/needle biopsies, results of a study showed.
T-cell receptor therapy safe, effective for soft tissue sarcoma
CHICAGO — A novel T-cell receptor therapy showed promising antitumor activity in patients with advanced soft tissue sarcoma, according to results from a phase 1 study presented at ASCO Annual Meeting.
ASTRO issues guideline on use of radiation therapy for adults with soft tissue sarcoma
American Society for Radiation Oncology issued its first clinical guideline for sarcoma.
FDA grants fast track designation to annamycin for sarcoma lung metastases
The FDA granted fast track designation to annamycin for the treatment of patients with lung metastases from soft tissue sarcoma, according to a press release from the agent’s manufacturer.